Inceptor Bio

Raleigh, United States

Inceptor Bio develops cell therapy solutions to cure difficult-to-treat cancers.

$21.0M raised

Feb 2025

Series A

Top Investors

Kineticos Disruptor FundKineticos Life SciencesKineticos Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Inceptor Bio raised?

Inceptor Bio has raised $21.0M in total funding. The most recent round was Series A. The last funding was announced in February 2025.

Who are Inceptor Bio's investors?

Inceptor Bio's investors include Kineticos Disruptor Fund, Kineticos Life Sciences, Kineticos Ventures.

Where is Inceptor Bio headquartered?

Inceptor Bio is headquartered in Raleigh, United States.

What does Inceptor Bio do?

Inceptor Bio develops cell therapy solutions to cure difficult-to-treat cancers.

What stage is Inceptor Bio at?

Inceptor Bio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 25, 2025.

MLA

"Inceptor Bio — Funding & Investors." VCBacked, February 25, 2025, https://www.vcbacked.co/company/inceptor-bio. Accessed June 17, 2026.

APA

VCBacked. (2025). Inceptor Bio — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/inceptor-bio

Wikipedia (cite web)

{{cite web |title=Inceptor Bio — Funding & Investors |url=https://www.vcbacked.co/company/inceptor-bio |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 25, 2025.